JP2004521942A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004521942A5 JP2004521942A5 JP2003507065A JP2003507065A JP2004521942A5 JP 2004521942 A5 JP2004521942 A5 JP 2004521942A5 JP 2003507065 A JP2003507065 A JP 2003507065A JP 2003507065 A JP2003507065 A JP 2003507065A JP 2004521942 A5 JP2004521942 A5 JP 2004521942A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- meta
- acid
- regioisomer
- para
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN511CH2001 | 2001-06-25 | ||
| PCT/IN2002/000135 WO2003000658A1 (en) | 2001-06-25 | 2002-06-19 | PROCESS FOR THE PREPARATION OF A HIGHLY PURE PHARMACEUTICAL INTERMEDIATE, 4-(CYCLOPROPYLCARBONYL)-α,α-DIMETHYLPHENYLACETIC ACID |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004521942A JP2004521942A (ja) | 2004-07-22 |
| JP2004521942A5 true JP2004521942A5 (enExample) | 2005-02-17 |
Family
ID=29765111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003507065A Pending JP2004521942A (ja) | 2001-06-25 | 2002-06-19 | 高純度医薬中間体である４−（シクロプロピルカルボニル）−α，α−ジメチルフェニル酢酸の製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6903232B2 (enExample) |
| EP (1) | EP1401815A1 (enExample) |
| JP (1) | JP2004521942A (enExample) |
| BG (1) | BG107476A (enExample) |
| SI (1) | SI21232A (enExample) |
| SK (1) | SK712003A3 (enExample) |
| WO (1) | WO2003000658A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8168234B2 (en) * | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| AU2003248657A1 (en) * | 2002-06-10 | 2003-12-22 | Teva Pharmaceutical Industries Ltd. | Polymorphic form xvi of fexofenadine hydrochloride |
| DE102004031849A1 (de) | 2004-06-30 | 2006-01-26 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Carbonylierung von Phenylalkylderivaten mit Kohlenmonoxid |
| WO2007007347A1 (en) * | 2005-07-07 | 2007-01-18 | Wockhardt Limited | Industrial process of fexofenadine hydrochloride with controlled side products |
| CN102659667B (zh) * | 2012-04-20 | 2013-08-14 | 浙江启明药业有限公司 | 一种非索非那定关键中间体的合成方法 |
| ITMI20131652A1 (it) * | 2013-10-07 | 2015-04-08 | Dipharma Francis Srl | Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico |
| US10696633B2 (en) | 2015-10-22 | 2020-06-30 | Sanofi-Aventis Deutschland Gmbh | Process for the preparation of fexofenadine and of intermediates used therein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1026147T3 (da) * | 1993-06-24 | 2004-03-22 | Albany Molecular Res Inc | Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater |
| US20020007068A1 (en) * | 1999-07-16 | 2002-01-17 | D'ambra Thomas E. | Piperidine derivatives and process for their production |
-
2002
- 2002-06-19 WO PCT/IN2002/000135 patent/WO2003000658A1/en not_active Ceased
- 2002-06-19 SK SK71-2003A patent/SK712003A3/sk unknown
- 2002-06-19 SI SI200220003A patent/SI21232A/sl not_active IP Right Cessation
- 2002-06-19 JP JP2003507065A patent/JP2004521942A/ja active Pending
- 2002-06-19 EP EP02745778A patent/EP1401815A1/en not_active Withdrawn
-
2003
- 2003-01-17 BG BG107476A patent/BG107476A/bg unknown
- 2003-07-02 US US10/612,637 patent/US6903232B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1026147B1 (en) | Compounds useful as intermediates in the production of piperidine derivatives | |
| US7923558B2 (en) | Method for obtaining pure tetrahydrocannabinol | |
| JP4330179B2 (ja) | テルフェナジン及び誘導体の合成 | |
| JP3066083B2 (ja) | １―ベンジル―４―（（５，６―ジメトキシ―１―インダノン）―２―イル）メチルピペリジンを調製する方法及びそのための中間物質 | |
| JP4344230B2 (ja) | ピペリジン誘導体フェキソフェナジンの製造方法 | |
| JP2004521942A5 (enExample) | ||
| US6903232B2 (en) | Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-α, α-dimethylphenylacetic acid | |
| AU2002320847A1 (en) | Process for the production of the piperidine derivative fexofenadine | |
| JP5585822B2 (ja) | 光学活性ニペコチン酸誘導体の製造方法 | |
| US7446203B2 (en) | Preparation of intermediates for acetycholinesterase inhibitors | |
| EP2261209A1 (en) | Novel crystalline forms of 4-[4-[4- hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenene acetic acid and its hydrochloride | |
| AU2001278094A1 (en) | Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride | |
| US7700779B2 (en) | Crystalline forms of fexofenadine and its hydrochloride | |
| EP1347960B1 (en) | Process for preparing (+) trans-4-p-fluorophenyl-3-hydroxymethyl-1 | |
| JPH0521105B2 (enExample) | ||
| JPH0681743B2 (ja) | α−（アルキルフェニル）−４−（ヒドロキシジフェニルメチル）−１−ピペリジンブタノールの製造方法 | |
| KR100953038B1 (ko) | 염산 도네페질의 개량된 제조방법 | |
| CA3097628A1 (en) | Intermediates and processes for the preparation of linagliptin and its salts | |
| AU2008202097A1 (en) | A Process for the Preparation of Keto Compounds | |
| JP3263377B2 (ja) | ３，５−ジヒドロキシ−６−オキソヘキサン酸エステル誘導体の製造法 | |
| JP2003160560A (ja) | トランス−４−置換ピペリジン−２−カルボン酸塩類の製造方法 | |
| WO2009136412A2 (en) | PROCESS FOR PREPARATION OF 4-[4-(4-(HYDROXYDIPHENYLMETHYL)- 1-PIPERIDINYL]-1-OXOBUTYL]-α,α-DIMETHYLBENZENE ACETIC ACID METHYL ESTER AND USE THEREOF | |
| WO2004043922A1 (en) | Method of preparation of terfenadine and its derivatives | |
| EP2289867A2 (en) | A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof |